President Donald Trump speaks to introduce the TrumpRx website at the South Court Auditorium of the White House on February 5, 2026 in Washington.
Saul Loeb | AFP | Getty Images
The Trump administration announced Monday that it will add generic drugs to its direct-to-consumer site TrumpRx, expanding a platform key to the administration’s efforts to lower prescription drug costs in the United States.
President Donald Trump said at an event Monday that his administration is adding more than 600 generic drugs to the site. The administration also built new tools into the platform, including the ability to connect patients with local pharmacies at the lowest prices and offer home delivery options for prescriptions.
He said the administration has partnered with certain industry players that have been selling drugs directly to consumers at transparent prices, including Mark Cuban’s Cost Plus Drug Company, Amazon Pharmacy and GoodRx. Cuban and other partner executives also attended Monday’s event.
“By incorporating a vast catalog of low-cost generic drugs into TrumpRx.gov, consumers will have real choice today by having one source to ensure they receive their prescriptions at the lowest possible cost,” President Trump said.
Until Monday, TrumpRx offered Americans a selection of branded products from manufacturers that had a landmark agreement with the administration to voluntarily lower the price of certain drugs. That includes Eli Lilly and Novo Nordisk’s blockbuster obesity drug, which has been listed on the site since its launch in February.
President Trump claimed Monday that the platform has been accessed more than 10 million times and has already saved Americans more than $400 million.
But it remains to be seen whether all patients, especially those with insurance, will see more cost savings by using the site to purchase drugs than through existing methods.
TrumpRx targets people who are willing to forgo insurance and pay cash, suggesting patients with no or limited coverage may benefit the most. The site also serves as a central hub that, although it does not sell drugs directly to U.S. patients, connects patients to drug companies that offer discounts on certain products on their direct-to-consumer sites and provides discount coupons to take to the pharmacy.
